X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TNXP

Closed

Tonix Pharmaceuticals Holding Corp

0.1425
0.0000 (0.00%)
Last Update: 06 Sep 2024 23:27:00
Yesterday: 0.1425
Day's Range: 0.1313 - 0.16
Send
When Written:
 
0.5802
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company that develops and commercializes drugs for psychiatric and neurological disorders. The company's lead product candidate is TNX-102 SL, a sublingual tablet formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder (PTSD). Tonix is also developing TNX-601, a small molecule antagonist of the corticotropin-releasing hormone type 1 receptor, for the treatment of PTSD and alcohol use disorder. The company was founded in 2007 and is headquartered in New York City.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:18.119.161.209
X